Meridian Bioscience (VIVO) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $5.87 --0%
Financial Fact:
AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC: -84.07M
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC: -84.07M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $47.2 million versus the consensus estimate of $48.6 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Amylyx ALS drug shows no serious adverse events in Phase 1 trial
- Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
